4 assets in Microcephaly 12, Primary, Autosomal Recessive

Therapeutic assets addressing Microcephaly 12, Primary, Autosomal Recessive, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Abemaciclib Microcephaly 12, Primary, Autosomal Recessive	Eli Lilly and Company	P3	B (60)
Abiraterone Microcephaly 12, Primary, Autosomal Recessive	Eli Lilly and Company	P3	B (60)
Prednisolone Microcephaly 12, Primary, Autosomal Recessive	Eli Lilly and Company	P3	B (60)
Prednisone Microcephaly 12, Primary, Autosomal Recessive	Eli Lilly and Company	P3	B (60)